Konstantinos Liatsikos (Kostas Liatsikos)
Publication Activity (10 Years)
Years Active: 2022-2023
Publications (10 Years): 4
Publications (10 Years): 4
Publications
- Elena Mitsi, Mariana O Diniz, Jesús Reiné, Andrea M Collins, Ryan E Robinson, Angela Hyder-Wright, Madlen Farrar, Konstantinos Liatsikos, Joshua Hamilton, Onyia Onyema, Britta C Urban, Carla Solórzano, Sandra Belij-Rammerstorfer, Emma Sheehan, Teresa Lambe, Simon J Draper, Daniela Weiskopf, Alessandro Sette, Mala K Maini, Daniela M Ferreira
- Esther L German, Helen M Nabwera, Ryan Robinson, Farah Shiham, Konstantinos Liatsikos, Christopher M Parry, Claire McNamara, Sanjana Kattera, Katie Carter, Ashleigh Howard, Sherin Pojar, Joshua Hamilton, Agnes Matope, Jonathan M Read, Stephen J Allen, Helen Hill, Daniel B Hawcutt, Britta C Urban, Andrea M Collins, Daniela M Ferreira, Elissavet Nikolaou
- Ryan E Robinson, Elena Mitsi, Elissavet Nikolaou, Sherin Pojar, Tao Chen, Jesús Reiné, Tinashe K Nyazika, James Court, Kelly Davies, Madlen Farrar, Patricia Gonzalez-Dias, Josh Hamilton, Helen Hill, Lisa Hitchins, Ashleigh Howard, Angela Hyder-Wright, Maia Lesosky, Konstantinos Liatsikos, Agnes Matope, Daniella McLenaghan, Christopher Myerscough, Annabel Murphy, Carla Solórzano-Gonzalez, Duo-Lao Wang, Hassan Burhan, Manish Gautam, Elizabeth Begier, Christian Theilacker, Rohini Beavon, Annaliesa S Anderson, Bradford D Gessner, Stephen Brian Gordon, Andrea M Collins, Daniela M Ferreira
- Konstantinos Liatsikos, Angela Hyder-Wright, Sherin Pojar, Tao Chen, Duo-Lao Wang, Kelly Davies, Christopher Myerscough, Jesus Reine, Ryan E Robinson, Britta Urban, Elena Mitsi, Carla Solorzano, Stephen B Gordon, Angela Quinn, Kaijie Pan, Annaliesa S Anderson, Christian Theilacker, Elizabeth Begier, Bradford D Gessner, Andrea Collins, Daniela M Ferreira, null nullProtocol for a phase IV double-blind randomised controlled trial to investigate the effect of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine on pneumococcal colonisation using the experimental human pneumococcal challenge model in healthy adults (PREVENTING PNEUMO 2). BMJ open 12 (7) (2022)